Antithrombin vs no thromboprophylaxis
Total VTE · ambulatory paediatric cancer patients newly diagnosed with acute lymphoblastic leukaemia who received chemotherapy
It is very uncertain whether antithrombin changes any VTE compared with no thromboprophylaxis (very low certainty).
1 finding from 1 review
- Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy 2020 · Cochrane Headline outcomes onlyRR 0.84 [0.41, 1.73]1 study · 85 participantsVery low